The first regulatory call does not need a complete technical file on screen. It needs enough controlled information to identify the product, test the assumptions and decide what must be reviewed next.

Basier uses an eight-document pre-assessment pack. It is not an SFDA submission checklist. Its purpose is to prevent the first meeting from being consumed by questions that the manufacturer could have answered in advance.

1. Manufacturer and device identity sheet

One page should name the legal manufacturer and sites, trade name, principal models, intended purpose, user, use environment and current markets. State whether the product is believed to be a medical device, IVD, software, accessory or system.

2. Model, accessory and SKU master list

Map each model to its catalogue code, accessories, pack and meaningful difference. This shows whether the project concerns one device, a family, a system or multiple regulatory units.

3. Intended purpose, claims, label and IFU

These documents expose the claims, manufacturer identity, warnings, storage conditions, product references and instructions actually attached to the product. They also reveal inconsistencies with the website or commercial deck.

4. Classification rationale

State the proposed class, rule or rationale and open questions. For an IVD, include analyte, specimen, user, testing context, intended purpose and principle of operation. Record uncertainty rather than forcing a premature conclusion.

5. Market-authorisation map

List current authorisations and certificates by jurisdiction, scope, covered models, manufacturing site, validity and pending change. Other-market status does not automatically decide the Saudi route, but it establishes the evidence baseline.

6. QMS certificate and site scope

Include the current certificate, scope, sites and covered activities. The relevant question is not only whether ISO 13485 exists, but whether the manufacturer, site and activity associated with the device are represented.

7. Technical-documentation index

Provide an index, not a document dump. Mark each section as current, requiring review or unavailable. Cover device description, risk management, verification and validation, clinical or IVD performance evidence, labelling and applicable specialised evidence such as software, cybersecurity, sterilisation or biological evaluation.

8. Proposed Saudi pathway and local roles

Describe the expected authorised representative, importer, distributor, service, storage, complaint and traceability arrangements—even if some roles remain undecided. State whether the immediate objective is registration, private launch, tender access or a wider market-entry programme.

The call should end with a decision

A prepared first call should produce one of four outputs:

  • a provisional pathway with defined validation questions;
  • a short evidence-gap list before the route can be estimated;
  • a decision to pause because a foundational issue is unresolved;
  • a phased scope beginning with assessment or remediation.

“Send the entire file and we will see” is not a useful first outcome.

Issue a short call record within one working day. Separate verified facts, unreviewed statements, assumptions and blocking questions, and link every requested follow-up document to the decision it will support. That discipline prevents the scope, cost or timeline from being built on meeting memory and gives the manufacturer a focused next action instead of another uncontrolled document request.

Official requirements versus preparation

SFDA marketing-authorisation, licensing, classification and grouping documents govern the applicable pathway. The eight-document pack is Basier’s preparation method; it is not proof of submission readiness or a substitute for the required application documentation. A missing item does not create an automatic rejection, and a complete pack does not by itself establish compliance.

Basier can review the pack, challenge assumptions and produce a route-and-gap map. Basier does not grant SFDA approval, verify documents that have not been reviewed or guarantee cost and timing before the product scope is understood.

Official sources

Turn the requirements into a clear plan for your case

Start with an assessment of the device and available evidence before deciding on submission.

Basier Regulatory Services